TUMOUR PEPTIDE ANTIGEN DERIVED FROM THE HUMAN CD19 PROTEIN

Details for Australian Patent Application No. 2002360062 (hide)

Owner IMMUGENICS AG

Inventors THEOBALD, Matthias; CELLARY, Anne

Pub. Number AU-A-2002360062

PCT Number PCT/EP02/14598

PCT Pub. Number WO2003/055907

Priority 101 63 755.1 27.12.01 DE

Filing date 19 December 2002

Wipo publication date 15 July 2003

International Classifications

C07K 014/47 Peptides having more than 20 amino acids

C12N 015/11 Mutation or genetic engineering - DNA or RNA fragments

A61K 038/08 Medicinal preparations containing peptides - Peptides having 5 to 11 amino acids

C07K 016/18 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

Event Publications

3 April 2003 Complete Application Filed

  Priority application(s): 101 63 755.1 27.12.01 DE

4 September 2003 Application Open to Public Inspection

  Published as AU-A-2002360062

16 September 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002360063-VALUE DOCUMENT AND DEVICE FOR PROCESSING VALUE DOCUMENTS

2002360061-SIGMA-DELTA CONVERTER COMPRISING NOISE SUPPRESSION